Phospholipids | Essentiale Rr solution for iv. enter 250 mg / 5 ml 5 ml ampoules 5 pcs.

Release form

Injectable solution

Packaging

5 ampoules 5 ml.

Pharmacological action of

The drug provides the liver, whose metabolic activity is impaired, with a high dose of ready-to-digest, high-energy “essential phospholipids”. These "essential phospholipids" are ideally combined with natural endogenous phospholipids in chemical structure. They mainly penetrate the liver cells, invading their membranes.

Essential phospholipids:

normalize liver function and liver cell enzyme activity

reduce liver energy consumption

promote liver cell regeneration

convert neutral fats and cholesterol to forms that facilitate their metabolism

stabilize the physicochemical properties of bile.

Indications

Fatty liver degeneration (including diabetes mellitus) acute and chronic hepatitis, cirrhosis of the liver, necrosis of liver cells, hepatic coma and precoma, toxic liver damage, toxicosis of pregnancy, pre- and postoperative treatment, especially during operations in the field hepatobiliary zone psoriasis radiation syndrome.

Contraindications

- Hypersensitivity to the drug.

IV solution cannot be used to treat newborns and premature babies.

Special instructions

Use only clear solution!

Composition of

5 ml of the solution contains: Active ingredient:

phosphatidylcholine from soybeans of a dried substance containing 93% (3-sn-phosphatidyl) choline: synonyms - “essential phospholipids”, “EPL®” - 250 mg.

Other ingredients:

benzyl alcohol - 45 mg,

deoxycholic acid –115 mg,

sodium chloride - 12 mg,

sodium hydroxide - 11.5 mg,

riboflavin - 0.5 mg,

- tocopherol - 0.75 mg,

ethanol –16.304 mg,

water for injection - 4543, 680 mg.

Dosage and administration

The drug is intended for intravenous administration, it should not be administered intramuscularly due to possible local irritation reactions. In the absence of other doctor's recommendations, 1-2 ampoules (5-10 ml) or in severe cases, 2-4 ampoules (10-20 ml) per day. The contents of 2 ampoules can be administered simultaneously. Do not mix in the same syringe with other drugs. It is recommended to dilute the solution with the patient's blood in a ratio of 1: 1.

If it is necessary to dilute the drug, only 5 or 10% dextrose solution for infusion administration is used, and the solution of the diluted drug should remain transparent throughout the entire time of administration.

Do not dilute the drug with electrolyte solutions (isotonic solution, Ringer's solution)!

It is recommended that parenteral administration be supplemented with oral administration of the drug as soon as possible.

Side effects of the

From the digestive system: when using the solution in high doses rarely - diarrhea when using capsules rarely - a feeling of discomfort in the abdomen.

Other: when using capsules rarely - allergic reactions.

Storage conditions

Store at a temperature not exceeding 8 РC.

active substance

Phospholipids

Terms and conditions otpuska IZ drugstore

prescription

waf Dosage form

infusion solution

Sanofi-Aventis, France